Jim Cramer on Pfizer: “I Can’t Come Up With Where the Growth Is”

Pfizer Inc. (NYSE:PFE) was among the stocks Jim Cramer shared his opinions on during Mad Money. A caller asked for Cramer’s thoughts regarding the stock, and he replied:

Okay, they do have earnings growth problems. They haven’t been able to make the Seagen acquisition work the way it should. The dividend is safe at 7%. I wish, I really wish I could be more positive. I just can’t be. It kills me to say that, a stock that yields 7, that used to have a lot of growth, that’s going to have growth again, but I can’t come up with where the growth is. I just can’t.

Pfizer Inc. (NYSE:PFE) develops and sells medicines and vaccines for several health conditions, including heart disease, infections, COVID-19, and rare diseases. During the May 11 episode, a caller asked if they should buy more, hold, or sell the stock, and Cramer responded:

Pfizer does not have any earnings momentum. You’re just buying it on that dividend yield of 6.66. And I’ve gotta tell you, if I want yield, I will go to bonds, not stocks.

While we acknowledge the risk and potential of PFE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PFE and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1